Matt Hancock interview on availability of Covid vaccines

The transcript discusses issues with vaccine delivery to GPs, highlighting a case where a GP was ready to administer 2500 vaccines but faced cancellations. The Oxford AstraZeneca vaccine is now being rolled out to GP surgeries after initial hospital trials. The main challenge is the supply of vaccines, and efforts are being made to increase it. Appreciation is expressed for the hard work of GP surgeries in vaccinating vulnerable groups.

What was the main issue faced by the GP surgeries in West London regarding vaccine delivery?

• They received more vaccines than needed.

• Their vaccine supply was reduced and delayed.

• They were unable to store the vaccines properly.

• They had too many staff to administer the vaccines.

What was the initial step taken before the Oxford AstraZeneca vaccine was distributed to GP surgeries?

• It was given to private clinics.

• It was tested in hospitals.

• It was distributed to pharmacies.

• It was sent to international locations.

What is the current limiting factor in the vaccine distribution process?

• The supply of vaccines.

• The number of available GP surgeries.

• The number of trained medical staff.

• The availability of storage facilities.

Which companies are being worked with to increase the vaccine supply?

• Pfizer and AstraZeneca

• Sinovac and Sputnik V

• Novavax and Bharat Biotech

• Moderna and Johnson & Johnson

Who is acknowledged for their efforts in the vaccine rollout?

• The pharmaceutical companies

• The government officials

• The GP surgeries

• The hospital staff